A Study of Oprozomib, Pomalidomide, and Dexamethasone in Adults With Primary Refractory or Relapsed and Refractory Multiple Myeloma
Clinical trial NCT01999335 · TERMINATED
Trial details
- NCT number
- NCT01999335
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-30
- Primary completion
- 2019-04-25
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.